← Back to Search

Behavioural Intervention

AI-Powered Counseling for Depression and Anxiety (SPEAC Trial)

N/A
Recruiting
Led By Jun Ma, MD, PhD
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age: ≥ 18 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 18 weeks
Awards & highlights

SPEAC Trial Summary

This trial studies ways to help people with mild-to-moderate depression/anxiety improve their emotional health via 8 coaching sessions.

Who is the study for?
Adults with mild-to-moderate, untreated depression or anxiety can join. They must score within certain ranges on the PHQ-9 and GAD-7 scales, be over 18 years old, and able to give informed consent in English. Exclusions include severe medical conditions, brain injuries or abnormalities, current heavy treatments for cancer, pregnancy or recent childbirth, other clinical trials participation that could interfere with this study's results.Check my eligibility
What is being tested?
The trial is testing a virtual voice-based coach called Lumen against human coaches to deliver Problem-Solving Treatment (PST) via an iPad or videoconference/phone. Participants will learn problem-solving skills over eight sessions to help manage daily problems contributing to their emotional distress.See study design
What are the potential side effects?
Since this trial involves counseling interventions rather than medications, traditional side effects are not expected. However, participants may experience discomfort discussing personal issues during sessions.

SPEAC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

SPEAC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 18 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 18 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Magnetic Resonance Imaging
Secondary outcome measures
Change from baseline Penn State Worry Questionnaire (PSWQ) at 18 weeks

SPEAC Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: Group 1: Lumen Coached GroupActive Control1 Intervention
Participants in this group will attend an Intervention Orientation session to receive the Coach Lumen tutorial, a study iPad, and a Lumen Intervention Workbook. They will complete 8 PST sessions with Coach Lumen using their study assigned iPad at home over 12 weeks. The first 4 sessions occur weekly and then the last 4 occur every other week. Participants will receive automated reminders on the day before and on the day of their scheduled session, and have the opportunity to reschedule sessions through the iPad. Participants will work with Coach Lumen to learn problem-solving skills to address current life challenges, plan activities, and complete home activities. Participants will also complete surveys before and after each PST session: a mood assessment survey before and a user experience survey after. At the end of study, Participants may be invited to provide their perspective regarding their Lumen use experience.
Group II: Group 2: Human Coached GroupActive Control1 Intervention
Participants in this group will receive a study iPad and Human-Coached Intervention Workbook and will complete the first of 8 PST sessions in person with a trained health coach. Participants' first PST session will be in person for approximately 1 hour. Participants will complete the remaining sessions remotely via Zoom (or by phone, if necessary) using their study iPad. The first 4 sessions occur weekly and then the last 4 occur every other week. Participants will receive automated reminder notifications on the day before and on the day of their scheduled session, and have the opportunity to reschedule sessions with their coach. Participants will also complete a mood assessment survey at the beginning of each PST session. Participants will work with their health coach to learn problem-solving skills to address current life challenges, plan activities, and complete home activities.
Group III: Group 3: Optional (Delayed) Lumen Coached GroupPlacebo Group1 Intervention
Participants assigned to this group can choose to attend a Lumen Orientation session to receive training and a study iPad to complete 8 PST sessions with Coach Lumen after their follow-up assessment at 18 weeks. They will receive 8 Sunday mood assessment surveys to complete (4 every Sunday and then 4 every other Sunday).

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
604 Previous Clinical Trials
1,558,795 Total Patients Enrolled
26 Trials studying Depression
6,831 Patients Enrolled for Depression
Penn State UniversityOTHER
353 Previous Clinical Trials
125,521 Total Patients Enrolled
13 Trials studying Depression
1,811 Patients Enrolled for Depression
Washington University School of MedicineOTHER
1,928 Previous Clinical Trials
2,296,763 Total Patients Enrolled
68 Trials studying Depression
23,179 Patients Enrolled for Depression

Media Library

Human Coached PST Intervention (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05603923 — N/A
Depression Research Study Groups: Group 1: Lumen Coached Group, Group 2: Human Coached Group, Group 3: Optional (Delayed) Lumen Coached Group
Depression Clinical Trial 2023: Human Coached PST Intervention Highlights & Side Effects. Trial Name: NCT05603923 — N/A
Human Coached PST Intervention (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05603923 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment into this experiment available currently?

"Unfortunately, this clinical trial isn't recruiting any more. The original announcement was on the 1st of January 2023 and it's since been updated lastly on October 28th 2022. Despite that, there are still 1333 other trials open to participants right now."

Answered by AI

Who else is applying?

What site did they apply to?
UIMC Advanced Imaging Center
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

I’ve tried meditation but nothing is working.
PatientReceived 1 prior treatment
~78 spots leftby Dec 2024